CS264865B1 - Alkoxy derivatives of aliphatic-aromatic ethers with halogen in the alkoxyalkyl group and the process for their preparation - Google Patents
Alkoxy derivatives of aliphatic-aromatic ethers with halogen in the alkoxyalkyl group and the process for their preparation Download PDFInfo
- Publication number
- CS264865B1 CS264865B1 CS8610305A CS1030586A CS264865B1 CS 264865 B1 CS264865 B1 CS 264865B1 CS 8610305 A CS8610305 A CS 8610305A CS 1030586 A CS1030586 A CS 1030586A CS 264865 B1 CS264865 B1 CS 264865B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- aliphatic
- halogen
- carbon atoms
- general formula
- aromatic ethers
- Prior art date
Links
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Podstatou řešení jsou alkoxyderiváty alifaticko-aromatických éterů s halogenem v alkoxyalkylskupině obecného vzorce I R1OCH2CHBrC(CH3)2-O o. (1) kde symbol R1 značí alkylskupinu s maximálně 5 atomy uhlíku, R2 značí alkylskupinu s maximálně 4 atomy uhlíku, chlor nebo alkoxyskupinu s maximálně 4 atomy uhlíku. Způsob přípravy spočívá v reakci nenasyceného éteru obecného vzorce II kde symbol R2 má výše uvedený význam, s alkanolem obecného vzorce III R1-OH (III) kde symbol R1 má výše uvedený význam a N-bromsukcinimidem při 0 až 5 °C. Látky vykazují biologickou účinnost.The essence of the solution is alkoxy derivatives of aliphatic-aromatic ethers with halogen in the alkoxyalkyl group of the general formula I R1OCH2CHBrC(CH3)2-O o. (1) where the symbol R1 denotes an alkyl group with a maximum of 5 carbon atoms, R2 denotes an alkyl group with a maximum of 4 carbon atoms, chlorine or an alkoxy group with a maximum of 4 carbon atoms. The preparation method consists in the reaction of an unsaturated ether of the general formula II where the symbol R2 has the above meaning, with an alkanol of the general formula III R1-OH (III) where the symbol R1 has the above meaning and N-bromosuccinimide at 0 to 5 °C. The substances show biological activity.
Description
Vynález se týká alkoxyderivátů alifaticko-aromatických éterů s halogenem v alkoxyalkylskupíně jako biologicky účinné látky a způsobu jejich přípravy.The invention relates to alkoxy derivatives of aliphatic-aromatic ethers with halogen in alkoxyalkyl as a biologically active substance and to a process for their preparation.
Podstatou předmětného vynálezu jsou alkoxyderiváty alifaticko-aromatických éterů s halogenem v alkoxyalkylskupině obecného vzorce I ^OC^CHBrClCHjlj-O—R2 (I) kde R1 značí alkylskupinu s maximálně 5 atomy uhlíku,The present invention provides alkoxy derivatives of aliphatic-aromatic ethers with halogen in the alkoxyalkyl group of the general formula (I) - (O ) - (CHCl 2 CH 3) i -O-R 2 (I) wherein R 1 represents an alkyl group having a maximum of 5 carbon atoms;
R značí alkylskupinu s maximálně 4 atomy uhlíku, chlor nebo alkoxyskupinu s maximálně 4 atomy uhlíku.R is alkyl of up to 4 carbon atoms, chlorine or alkoxy of up to 4 carbon atoms.
Způsob přípravy skupině se vyznačuje alkoxyderivátů alifaticko-aromatických éterů s halogenem v alkoxyalkyltím, že se nechá nenasycený éter obecného vzorce IX — ch2=ch—c(ch3)2—o (II) kde symbol R má výše uvedený význam reagovat s alkanolem obecného vzorce IIIThe process for preparing a group is characterized by alkoxy derivatives of aliphatic-aromatic ethers with halogen in the alkoxyalkyl group by leaving an unsaturated ether of the general formula IX - ch 2 = ch - c (ch 3 ) 2 - o (II) wherein R is as defined above with alkanol of formula III
R1-OH (III) kde symbol R^ má výše uvedený význam a N-bromsukcinimidem při teplotě 0 až 5 °C za vzniku produktu obecného vzorce I.R 1 -OH (III) wherein R 1 is as defined above and with N-bromosuccinimide at 0-5 ° C to give the product of formula (I).
V dalším je vynález blíže objasněn na příkladu provedení, aniž se na tento výlučně omezuje.In the following, the invention is explained in more detail by way of example without being limited thereto.
Příklad (1,l-dimethyl-2-propenyl)-(4-chlorfenyl)éter (0,01 mol) se nechá reagovat v prostředí bezvodého methanolu v atmosféře suchého dusíku s 0,017 molárním množstvím N-bromsukcinimidu. Vše bylo mícháno při teplotě 0 až 5 °C po dobu 15 minut a pak bylo zředěno vodou a extrahováno diethyléterem. Po vysušeni éterické vrstvy nad bezvodým síranem hořečnatým a odpaření rozpouštědla byl zbytek chromatografován na silikagelu s 8 hmot. % vody (elučni činidlo petroléter obsahující až 10 obj. % diethyléteru). Bylo tak získáno například 1,0 g (70 %) (2-brom—1,l-dimethyl-3-methoxypropyl)-(4-chlorfenyl)éteru.Example (1,1-Dimethyl-2-propenyl) - (4-chlorophenyl) ether (0.01 mol) was treated with 0.017 molar amount of N-bromosuccinimide under anhydrous methanol under a dry nitrogen atmosphere. Stir at 0-5 ° C for 15 minutes and then dilute with water and extract with diethyl ether. After drying the ether layer over anhydrous magnesium sulfate and evaporating the solvent, the residue was chromatographed on silica gel with 8 wt. % water (eluent petroleum ether containing up to 10 vol% diethyl ether). Thus, for example, 1.0 g (70%) of (2-bromo-1,1-dimethyl-3-methoxypropyl) - (4-chlorophenyl) ether was obtained.
IC analýza (CC14, 5 %) : 2 834 (YCHj v OCH3) , 1 598, 1 584, 1 496 (\)arom.),IC analysis (CCl 4 , 5%): 2,834 (YCH 3 in OCH 3 ), 1,598, 1,584, 1,496 ()) arom.,
466 (cT . CH,), (CH,): 1 369, 1 384, 1 393 cm-1.466 (ct, CH3), (CH3): 1369, 1384, 1393 cm -1 .
SCI S · 2. S »5SCI S · 2 S 5
MS analýza: 306/8/10 <M+) , (C^H^BrClop , 128/30 (CgH^lO) , 73(C4HgO).MS analysis: 306/8/10 <M), (C ^ H ^ BrClop, 128/30 (CGH-LO), 73 (C 4 H O g).
Stejným způsobem byly připraveny:In the same way they were prepared:
(2-brom-l,l-dimethyl-3-methoxypropyl)-(4-ethylfenyl)éter a (2-brom-l,l-dimethyl-3-methoxypropyl)-(4-methoxyfenyl)éter.(2-bromo-1,1-dimethyl-3-methoxypropyl) - (4-ethylphenyl) ether and (2-bromo-1,1-dimethyl-3-methoxypropyl) - (4-methoxyphenyl) ether.
(2-brom-l,l-dimethyl-3-methoxypropyl)-(4-ethylfenyl)éter:(2-Bromo-1,1-dimethyl-3-methoxypropyl) - (4-ethylphenyl) ether:
IC analýza (CC14, 5 %) : 2 834 (l) CH v OCHj) , 1 613, 1 585, 1 516 (V aromatika) ,IC analysis (CCl 4 , 5%): 2,834 (1) CH in OCH 3), 1,613, 1,585, 1,516 (V aromatics),
466 (cTsCH2), 1 393, 1 384, 1 368 (ΰζ (CH3) 2)cm_1.466 (CT CH 2), 1393, 1384, 1368 (ΰζ (CH 3) 2) cm _1.
MS analýza: 300/2 (M+, c14H2iBrO2) , 135 (CgH^O) .MS analysis: 300/2 (M + , c 14 H 21 BrO 2 ) , 135 (C 8 H 16 O).
(2-brom-l,l-dimethyl-3-methoxypropyl)-(4-methoxyfenyl)éter:(2-Bromo-1,1-dimethyl-3-methoxypropyl) - (4-methoxyphenyl) ether:
IC analýza (CC1., 5 %): 2 985 (Ú CH v OCH,), 2 835(\)cH v OCH,), 1 612, rk 35 J nIC analysis (CCl., 5%): 2,985 (CH in OCH,), 2,835 ()H in OCH,), 1,612, rk 35 J n
593, 1 514 (\) aromatika), 1 393, 1 374, 1 368 (<j g (CHj) 2) cm .593, 1514 ([alpha] aromatics), 1393, 1374, 1368 ([mu] g (CH2) 2 ) cm.
MS analýza: 302/4(M+,C13HlgBrO3), 124(C7HgO2).MS analysis: 302/4 (M +, C 13 H 3 BrO g), 124 (C 7 H 2 O g).
Biologické účinky byly sledovány:Biological effects were monitored:
u svilušky Tetranychus urticae. Pro (2-brom-l,l-dimethyl-3-methoxypropyl)-(4-ethylfenyl)éter: -2 topikální aplikace 10 obj. % (5 |Ul) na listy fazole: 12 svilušek nakladlo za 96 hodin 76 vajíček, jež byla během 7 dnů všechna mrtvá a nic se z nich nelíhlo.in spider mite Tetranychus urticae. For (2-bromo-1,1-dimethyl-3-methoxypropyl) - (4-ethylphenyl) ether: -2 topical application of 10 vol% (5 µl) to bean leaves: 12 spider mites laid 76 eggs in 96 hours, which was all dead within 7 days and none of them hatched.
_2_2
Pro (2-brom-l,l-dimethyl-3-methoxypropyl)-(4-methoxyfenyl)éter: 10 obj. %: 12 svilušek za 96 hodin nakladlo 6 vajíček, všechna po 7 dnech mrtvá (nic se z nich nevylíhlo).For (2-bromo-1,1-dimethyl-3-methoxypropyl) - (4-methoxyphenyl) ether: 10 vol%: 12 spider mites laid 6 eggs in 96 hours, all dead after 7 days (none hatched) .
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS8610305A CS264865B1 (en) | 1986-12-30 | 1986-12-30 | Alkoxy derivatives of aliphatic-aromatic ethers with halogen in the alkoxyalkyl group and the process for their preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS8610305A CS264865B1 (en) | 1986-12-30 | 1986-12-30 | Alkoxy derivatives of aliphatic-aromatic ethers with halogen in the alkoxyalkyl group and the process for their preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CS1030586A1 CS1030586A1 (en) | 1988-12-15 |
| CS264865B1 true CS264865B1 (en) | 1989-09-12 |
Family
ID=5448593
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS8610305A CS264865B1 (en) | 1986-12-30 | 1986-12-30 | Alkoxy derivatives of aliphatic-aromatic ethers with halogen in the alkoxyalkyl group and the process for their preparation |
Country Status (1)
| Country | Link |
|---|---|
| CS (1) | CS264865B1 (en) |
-
1986
- 1986-12-30 CS CS8610305A patent/CS264865B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CS1030586A1 (en) | 1988-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2024527C1 (en) | Method of macrolide compounds synthesis | |
| CN113943238B (en) | Substituted diphenyl sulfide compound and application thereof | |
| Andrawes et al. | Degradation and elimination of Temik in rats | |
| March et al. | Metabolism of systox in the white mouse and American cockroach | |
| CA1202967A (en) | Milbemycin d derivatives, their preparation and compositions containing them | |
| EP0216625A2 (en) | Pesticidal compounds | |
| CS264865B1 (en) | Alkoxy derivatives of aliphatic-aromatic ethers with halogen in the alkoxyalkyl group and the process for their preparation | |
| US4105790A (en) | α-Amino ketone derivatives | |
| US3784605A (en) | 2-(polysubstituted phenyl)-1,3-indandione compounds | |
| US3803240A (en) | 2-(2,6-substituted-phenyl)-1,3-indandiones | |
| US4567169A (en) | Nitrosourea substituted phosphonates and pharmaceutical use | |
| US3518074A (en) | Benzoylcholine halides as plant growth stunting agents | |
| JP3147321B2 (en) | New milbemycin compounds | |
| US5266589A (en) | Method of increasing the muscle/fat ratio in agricultural domestic animals | |
| JPH021147B2 (en) | ||
| IL32639A (en) | Heterocyclic thio-or dithio-phosphoric acid esters,their manufacture and use as pesticides | |
| Neville et al. | Phosphorus metabolism during transport of calcium | |
| CS269381B1 (en) | S-succinic acid semi-ester with 4- (3-alkoxy-3-alkyl-2-bromobutoxy) phenylalkanol as biologically active substance and method for its preparation | |
| SU674652A3 (en) | Insecto-cariocido-nematocide composition | |
| Baer et al. | PHOSPHONOLIPIDS: XI. SYNTHESIS OF PHOSPHONOLIPID METABOLITES. l-α-GLYCERYL-(2-TRIMETHYLAMMONIUMETHYL) PHOSPHONATE | |
| IL35041A (en) | Phosphonic acid esters,their manufacture and pesticidal compositions containing them | |
| CS269386B1 (en) | ¢ 3,7-Dialkoxy-3,7-dialkyl-2-bromoctyl) - (4-chlorophenyl ether) as a biologically active substance and a process for its preparation | |
| CS252629B1 (en) | Biologically active halogen-containing 2H-benzopyran derivatives per molecule and method for their preparation | |
| CS270350B1 (en) | 3- (2,2-dihalomethananyl) -2,2-dimethylcyclopropanecarboxylic acid 1- [4- (3-alkoxy-3-alkyl-2-halobutoxy) phenyl] ester as a biologically active substance and its preparation process | |
| IL26309A (en) | Phosphoric and thiophosphoric acid derivatives |